🎯 Dronacharya Mentorship 2026–27 batch now open β€” limited seats. Ask on WhatsApp β†’

Why South Asians Are Missing from Global Health Databases β€” UPSC Mains Notes (GS Paper II)

UPSC Mains GS Paper II Health & Genomics Equity

Why South Asians Are Missing from Global Health Databases

South Asians make up over 20% of humanity but account for less than 1% of participants in major genetic studies β€” a gap that risks entrenching health inequity in the age of AI-driven medicine
GENETIC STUDY SHARE
<1% of GWAS Catalogue Participants
POPULATION SHARE
Over 20% of World’s Population
INDIA’S DIABETES BURDEN
Projected 125 Million by 2045
πŸ“°

Why in News

  • A recent Lancet Regional Health – Southeast Asia perspective warns that South Asia risks being left behind in the genomic revolution without its own health-data infrastructure.
  • AI and Machine Learning increasingly use genetic data for early disease detection, risk prediction and personalised treatment β€” but global genetic datasets remain dominated by European populations.
  • Between 2005 and 2025, over 86% of participants in the NHGRI-EBI GWAS Catalogue were of European ancestry, while South Asians were less than 1%.

The Core Problem

  • The medical tools of the future are being trained mostly on the genes of European people β€” so when applied to South Asians, they often give less accurate results, even though South Asians face higher disease risks.
  • Globally, more than 1 in 10 adults now live with diabetes; people of South Asian origin face even higher risk, striking at a younger age.
⚠️

Why This Matters β€” Significance of the Issue

  • Higher disease burden: South Asians suffer higher rates of type 2 diabetes, cardiovascular disease and asthma than Europeans β€” yet tools built on European data are least accurate for the very population that needs them most.
  • Inaccurate risk prediction: A 2023 study found polygenic risk scores for multiple sclerosis were less accurate when applied to South Asians; diagnostic thresholds built on European data may misjudge disease risk in Indians.
  • Wrong drug targets: Since most gene-disease findings are based on European data, scientists cannot be sure which findings apply to South Asians β€” limiting the discovery of drugs suited to South Asian bodies.
  • AI will multiply the bias: If underlying data stays biased, AI models and clinical tools built on it will repeat and magnify those biases at scale β€” the biggest danger.
🚨
Neglecting over 20% of the world’s population in health data denies them the right and opportunity to achieve the best possible health β€” a question of health equity and human rights.
🧬

South Asia Is Not One Single Population

  • South Asia is one of the most genetically diverse regions in the world, shaped by thousands of years of migration, endogamy and consanguineous marriages.
  • Much research wrongly lumps together South Asians, Southeast Asians and West Asians, hiding critical differences.
  • The GenomeIndia Project (launched 2020) has already identified more than 40 million genetic variants unique to Indian populations.
  • Traits like G6PD deficiency vary sharply even within South Asia β€” some ethnic groups in Pakistan and Afghanistan carry it at much higher rates.
Note: India and South Asia cannot be treated as “one genetic block.” Tribal groups, endogamous communities and diverse regions must be included β€” not just a few urban populations.
❓

Why Is the Data Missing?

Historical Funding Inequality

Research money and biobanks were built where wealth already existed; LMICs were left with weak lab infrastructure and few trained personnel.

Global Imbalance in Priorities

Over 90% of the world’s potential years of life lost occur in LMICs, yet only ~10% of global health research funding addresses their needs.

Competing Public Health Priorities

Infectious diseases, maternal and child health are more urgent for most South Asian nations, so genomic research is often deprioritised.

Fragmented, Non-Harmonised Data

South Asia has built several good cohorts, but different data systems make it hard to combine them for large studies.

Steps Already Taken

  • GenomeIndia Project β€” to map India’s genetic diversity.
  • Phenome India and Longevity India β€” large cohort studies.
  • Sri Lankan Twin Registry Biobank and the Pakistan Genome Resource.
🧭

Way Forward

Regional Collaboration
Connect existing biobanks and cohorts across India, Pakistan, Bangladesh and Sri Lanka so datasets can “speak to each other.”
Data Harmonisation
Create common standards for collecting and storing data so researchers can work across cohorts easily.
Data Sovereignty
South Asian researchers and institutions must retain a meaningful role in how their own data is used.
Recalibrate Global Tools
Risk scores and prediction models built on European data should be validated and adjusted using South Asian data.
Include True Diversity
Cover tribal, rural and endogamous groups, not just urban populations.
Increase Research Funding
Governments and global bodies must invest more in genomic research in LMICs to correct the historical imbalance.
Conclusion: The AI-powered genomic revolution holds enormous promise, but if built on biased, non-diverse data it will deepen the very inequalities it should solve. As one expert put it, “It may be late, but still not too late.”
πŸ“°
Source: The Hindu

This will close in 0 seconds

Scroll to Top